Strongbridge Biopharma plc.
SBBP
SBBP was delisted on the 5th of October, 2021.
60 hedge funds and large institutions have $48.8M invested in Strongbridge Biopharma plc. in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 11 closing their positions.
18% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 11
11% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 18
3% more funds holding
Funds holding: 58 → 60 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $49.7M → $48.8M (-$898K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$8.82M |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$1.01M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$925K |
| 4 |
JP Morgan Chase
New York
|
+$923K |
| 5 |
Renaissance Technologies
New York
|
+$839K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Prosight Management
Dallas,
Texas
|
-$2.63M |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.73M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.36M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$903K |
| 5 |
D.E. Shaw & Co
New York
|
-$878K |
SBBP Hedge Fund Activity: Q1 2020 in Review
60 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Strongbridge Biopharma plc. (SBBP) for Q1 2020, worth a combined $48.8M — down 1.8% from $49.7M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new SBBP positions and 11 closed out — a net gain of 2 holders — while 20 added to existing stakes and 18 trimmed.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $8.82M. The largest seller was Prosight Management, exiting entirely with an estimated $2.63M sold.
- 60 institutional investors held Strongbridge Biopharma plc. (SBBP) as of Q1 2020, up from 58 in Q4 2019.
- Funds reported $48.8M of Strongbridge Biopharma plc. stock for Q1 2020, down 1.8% quarter-over-quarter.
- 13 funds opened new Strongbridge Biopharma plc. positions in Q1 2020 and 11 closed out, a net change of +2 holders.
- The largest Strongbridge Biopharma plc. buyer in Q1 2020 was Ikarian Capital, an estimated $8.82M added.
- The largest Strongbridge Biopharma plc. seller in Q1 2020 was Prosight Management, an estimated $2.63M sold.
Based on aggregated 13F filings for Q1 2020.